Trial Profile
An Efficacy, Safety, and Tolerability Study of Daily Dosing With Levalbuterol, Racemic Albuterol, and Placebo in Pediatric Subjects With Asthma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Aug 2023
Price :
$35
*
At a glance
- Drugs Levosalbutamol (Primary) ; Salbutamol
- Indications Asthma
- Focus Therapeutic Use
- Sponsors Sumitomo Pharma America
- 23 Apr 2015 New trial record